A Unified Approach to Synthesizing Four Linezolid Metabolites That May Cause Thrombocytopenia
<b>Background/Objectives</b>: Linezolid is a first-in-class oxazolidinone antibiotic that exhibits activity against Gram-positive pathogens, including methicillin-resistant <i>Staphylococcus aureus</i> and vancomycin-resistant enterococci. However, its clinical use is often restricted because of hem...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2025-11-01
|
| Col·lecció: | Pharmaceuticals |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/1424-8247/18/12/1821 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|